Published in J Surg Res on November 19, 2011
Μanagement of patients with hepatitis B and C before and after liver and kidney transplantation. World J Hepatol (2014) 0.80
Hepatitis C virus infection. N Engl J Med (2001) 18.67
Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med (1999) 15.69
Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology (1982) 11.24
Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet (1997) 10.05
Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients. Transplantation (2007) 3.69
Fibrosis progression after liver transplantation in patients with recurrent hepatitis C. J Hepatol (2004) 3.56
Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology (2002) 2.37
Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis (2008) 2.01
Suppression of hepatitis C virus replication by cyclosporin a is mediated by blockade of cyclophilins. Gastroenterology (2005) 1.85
Acute hepatitis C. Lancet (2008) 1.76
Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut (2002) 1.65
Natural history of HCV infection. Baillieres Best Pract Res Clin Gastroenterol (2000) 1.61
Epidemiology of hepatitis C virus. A preliminary study in volunteer blood donors. JAMA (1990) 1.55
Hepatitis C: the clinical spectrum of the disease. J Hepatol (1999) 1.55
A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group. Lancet (1995) 1.54
Association between hepatitis C infection and other infectious diseases: a case for targeted screening? Am J Gastroenterol (2003) 1.26
Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C. Transplantation (2007) 1.08
Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Transplantation (2004) 1.07
The impact of transplantation with deceased donor hepatitis c-positive kidneys on survival in wait-listed long-term dialysis patients. Am J Transplant (2004) 1.07
Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy. Transplantation (2003) 1.07
A model to predict severe HCV-related disease following liver transplantation. Hepatology (2003) 1.06
Impact of immunosuppressive therapy on recurrence of hepatitis C. Liver Transpl (2002) 1.03
Increased immunosuppressive vulnerability in elderly renal transplant recipients. Transplantation (2000) 1.01
Immunosuppression of the elderly kidney transplant recipient. Transplantation (2007) 0.93
The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age. Liver Transpl (2008) 0.92
Increased infections in liver transplant recipients with recurrent hepatitis C virus hepatitis. Transplantation (1996) 0.92
Influence of age and date of infection on distribution of hepatitis C virus genotypes and fibrosis stage. J Viral Hepat (2003) 0.90
Transmission of HCV by organ transplantation. N Engl J Med (1992) 0.86
Survival of mandatorily shared cadaveric kidneys and their paybacks in the zero mismatch era. Transplantation (2002) 0.85
Renal transplantation in older adults: is graft survival affected by age? A case control study. Transplantation (2000) 0.85
Hepatitis C and renal transplantation in the era of modern immunosuppression. J Am Soc Nephrol (2003) 0.84
Management of lymphoceles after renal transplantation: laparoscopic versus open drainage. J Urol (2003) 0.84
Impact of hepatitis on renal transplantation. Transplantation (1981) 0.83
Management of lymphoceles after kidney transplantation. Transpl Int (1998) 0.82
Kidney transplantation from donors with viral B and C hepatitis. Transplant Proc (2006) 0.82
Immunosuppression in elderly renal transplant recipients: are current regimens too aggressive? Drugs Aging (2001) 0.82
Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 2: hepatitis C virus). Transpl Infect Dis (2002) 0.80
The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int (1994) 0.79
Hemodialysis in elderly patients. Int Urol Nephrol (2000) 0.79
Need for individualized immunosuppression in elderly renal transplant recipients. Transplant Proc (2001) 0.79
Long-term results of kidney transplantation from HCV-positive donors. Transplant Proc (2007) 0.78
Impact of cyclosporine-based immunosuppressive therapy on liver histology of hepatitis C virus-infected renal transplant patients. Hepatology (2008) 0.78
Prevention of lymphoceles following renal transplantation. Ann Surg (1976) 0.78
Induction immunosuppression for patients who underwent transplantation for cirrhosis caused by hepatitis C? The answer is no! Liver Transpl (2002) 0.77
The incidence of hepatitis C virus positive serological test results among cornea donors. Cell Tissue Bank (2000) 0.76
Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis (2010) 6.59
Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study. Lancet Infect Dis (2012) 5.24
Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function. N Engl J Med (2015) 5.12
Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm (2013) 5.02
Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology (2008) 4.26
Does the addition of glutamine to enteral feeds affect patient mortality? Crit Care Med (2005) 3.43
The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury. Kidney Int (2008) 3.30
Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care (2012) 3.20
Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria. Liver Transpl (2014) 3.11
Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis (2003) 2.92
NKT cell activation mediates neutrophil IFN-gamma production and renal ischemia-reperfusion injury. J Immunol (2007) 2.92
Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect (Larchmt) (2010) 2.67
Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg (2005) 2.64
Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology (2005) 2.63
A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl (2005) 2.56
Management of the Potential Organ Donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement. Crit Care Med (2015) 2.42
Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl (2002) 2.28
Intravenous lidocaine is as effective as epidural bupivacaine in reducing ileus duration, hospital stay, and pain after open colon resection: a randomized clinical trial. Reg Anesth Pain Med (2010) 2.28
Human β cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes. Cell Metab (2012) 2.22
Wound infection after elective colorectal resection. Ann Surg (2004) 2.21
Improving liver allocation: MELD and PELD. Am J Transplant (2004) 2.14
Bilateral adrenal hemorrhage: the unrecognized cause of hemodynamic collapse associated with heparin-induced thrombocytopenia. Crit Care Med (2011) 2.06
Cost of Gram-negative resistance. Crit Care Med (2007) 2.05
Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl (2002) 2.03
Dendritic cells tolerized with adenosine A₂AR agonist attenuate acute kidney injury. J Clin Invest (2012) 2.00
Total pancreatectomy and islet autotransplantation for chronic pancreatitis. J Am Coll Surg (2012) 2.00
Donor morbidity after living donation for liver transplantation. Gastroenterology (2008) 1.90
The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant (2005) 1.90
Effects of preoperative skin preparation on postoperative wound infection rates: a prospective study of 3 skin preparation protocols. Infect Control Hosp Epidemiol (2009) 1.89
Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br J Haematol (2005) 1.87
Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis (2007) 1.78
Ten-year outcome after rapid discontinuation of prednisone in adult primary kidney transplantation. Clin J Am Soc Nephrol (2012) 1.69
Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation. Am J Transplant (2003) 1.65
Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome. J Infect Dis (2009) 1.62
Early and late onset Clostridium difficile-associated colitis following liver transplantation. Transpl Int (2007) 1.62
Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma. Liver Transpl (2007) 1.61
Predictors associated with terminal renal function in deceased organ donors in the intensive care unit. Anesthesiology (2009) 1.60
Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis. Clin Infect Dis (2009) 1.60
Contact isolation in surgical patients: a barrier to care? Surgery (2003) 1.60
Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt) (2013) 1.60
Outbreak of resistant Pseudomonas aeruginosa infections during a quarterly cycling antibiotic regimen. Surg Infect (Larchmt) (2008) 1.58
Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation. Liver Transpl (2007) 1.58
Surgical site infection prevention: the importance of operative duration and blood transfusion--results of the first American College of Surgeons-National Surgical Quality Improvement Program Best Practices Initiative. J Am Coll Surg (2008) 1.56
Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation. J Am Soc Nephrol (2005) 1.54
Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation (2003) 1.54
Safety of cardiac catheterization in patients with end-stage liver disease awaiting liver transplantation. Am J Cardiol (2009) 1.53
Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus. Liver Transpl (2011) 1.52
Outcomes with split liver transplantation in 106 recipients: the University of California, San Francisco, experience from 1993 to 2010. Arch Surg (2011) 1.51
Blood transfusions correlate with infections in trauma patients in a dose-dependent manner. Am Surg (2002) 1.50
Use of CT cholangiography to evaluate the biliary tract after liver transplantation: initial experience. Liver Transpl (2004) 1.50
Invasive aspergillosis in the recipients of liver retransplantation. Liver Transpl (2006) 1.49
Expanding the donor pool: can the Spanish model work in the United States? Am J Transplant (2003) 1.48
Factors influencing liver transplant length of stay at two large-volume transplant centers. Liver Transpl (2009) 1.48
Identification of risk factors for the development of clostridium difficile-associated diarrhea following treatment of polymicrobial surgical infections. Ann Surg (2010) 1.47
The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: an executive summary. Surg Infect (Larchmt) (2002) 1.47
Calcineurin inhibitor-free mycophenolate mofetil/sirolimus maintenance in liver transplantation: the randomized spare-the-nephron trial. Liver Transpl (2013) 1.46
Sorafenib therapy for hepatocellular carcinoma prior to liver transplant is associated with increased complications after transplant. Transpl Int (2011) 1.46
Trends over a decade of pediatric liver transplantation in the United States. Liver Transpl (2006) 1.45
Self expandable metal stents for anastomotic stricture following liver transplant. Dig Dis Sci (2013) 1.45
Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant (2002) 1.44
Advanced recipient age (>60 years) alone should not be a contraindication to liver retransplantation. Transpl Int (2009) 1.43
The surgical care improvement project and prevention of post-operative infection, including surgical site infection. Surg Infect (Larchmt) (2011) 1.43
Offer patterns of nationally placed livers by donation service area. Liver Transpl (2013) 1.42
Temporary placement of fully covered self-expandable metal stents in benign biliary strictures: midterm evaluation (with video). Gastrointest Endosc (2009) 1.41
Patient selection for liver transplant: 1-year experience with 555 patients at a single center. Mayo Clin Proc (2008) 1.39
Preventing antimicrobial-resistant bacterial infections in surgical patients. Surg Infect (Larchmt) (2002) 1.39
The vascular nature of hemorrhoids. J Gastrointest Surg (2006) 1.38
Estradiol is associated with mortality in critically ill trauma and surgical patients. Crit Care Med (2008) 1.37
Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients. Crit Care Med (2003) 1.34
Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. JAMA (2012) 1.33
Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition. J Immunol (2007) 1.32
Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies. Am J Transplant (2003) 1.31
Liver allografts from hepatitis C positive donors can offer good outcomes in hepatitis C positive recipients: a US National Transplant Registry analysis. Transpl Int (2010) 1.25
A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy. Liver Transpl (2003) 1.25
Obesity and pulmonary complications in critically injured adults. Chest (2008) 1.24
Accuracy of plain abdominal radiographs in the detection of retained surgical needles in the peritoneal cavity. Ann Surg (2008) 1.24
The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: evidence for the recommendations. Surg Infect (Larchmt) (2002) 1.23
Rapid apoptosis induced by Shiga toxin in HeLa cells. Infect Immun (2003) 1.23
Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors. Clin Neurol Neurosurg (2010) 1.22
Acute kidney injury during liver transplantation as determined by neutrophil gelatinase-associated lipocalin. Liver Transpl (2009) 1.20
Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA. Liver Transpl (2004) 1.19
Efficacy of protocol implementation on incidence of wound infection in colorectal operations. J Am Coll Surg (2007) 1.19
Glucose regulation of insulin gene transcription and pre-mRNA processing in human islets. Diabetes (2007) 1.17
Metabolic profiling of livers and blood from obese Zucker rats. J Hepatol (2005) 1.16
High levels of endogenous estrogens are associated with death in the critically injured adult. J Trauma (2008) 1.16
Can we define the ideal duration of antibiotic therapy? Surg Infect (Larchmt) (2006) 1.15